Effects of repeated cyclosporin A administration on iminodipropionitrile-induced dyskinesia and TRE-/CRE-binding activities in rat brain

Neuroscience Research

Volumn 30, Issue 2, 1998, Pages 185-193

  Iida, Kyoko ^a   Iwata, Emi ^a   Asanuma, Masato ^a   Asanuma, Sakiko N ^a   Gómez Vargas, Marvin ^a   Miyazaki, Ikuko ^a   Nakanishi, Tohru ^a   Ogawa, Norio ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Basal ganglia; D1 D2 receptor mRNA; Dopamine system; Immunophilin; Transcription factor; Tyrosine hydroxylase

Indexed keywords

3,3' IMINODIPROPIONITRILE; CYCLOSPORIN A; DOPAMINE; DOPAMINE 1 RECEPTOR; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; TRANSCRIPTION FACTOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; CYCLIC AMP RESPONSIVE ELEMENT; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; DYSKINESIA; ELECTROPHORETIC MOBILITY; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RECEPTOR GENE;

EID: 0031905653     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-0102(97)00128-4     Document Type: Article

References (47)

1. Asanuma M., Nishibayashi S., Iwata E., Kondo Y., Nakanishi T., Gómez-Vargas M., Ogawa N. Alterations of cAMP response element-binding activity in the aged rat brain in response to administration of rolipram, a cAMP-specific phosphodiesterase inhibitor. Mol. Brain Res. 41:1996;210-215.
2. Asanuma M., Nishibayashi S., Kondo Y., Iwata E., Tsuda M., Ogawa N. Effects of single cyclosporin A pretreatment on pentylenetetrazole-induced convulsion and on TRE-binding activity in the rat brain. Mol. Brain Res. 33:1995;29-36.
3. Asanuma M., Ogawa N., Nishibayashi S., Kondo Y., Mori A. Effects of repeated injection of cyclosporin A on pentylenetetrazole-induced convulsion and cyclophilin mRNA levels in rat brain. Neurochem. Res. 20:1995;101-105.
4. Berden J.H.M., Hottsuma A.J., Merx J.L., Keyser A. Severe central-nervous-system toxicity accociated with cyclosporin. Lancet. i:1985;219-220.
5. Boespflug O., Godfraind C., Tardieu M. Effect of cyclosporin A on an experimental chronic viral infection on the central nouvous system. J. Neuroimmunol. 21:1989;49-57.
6. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
7. 3H-prazosine in rat brain following iminodipropionitrile administration. Soc. Neurosci. Abst. 12:1986;1563.
8. 2 dopamine receptor cDNA. Nature. 336:1988;783-787.
9. Cadet J.L. The iminodipropionitrile (IDPN)-induced dyskinetic syndrome: behavioral and biochemical pharmacology. Neurosci. Biobehav. Rev. 13:1989;39-45.
10. Cadet J.L., Karouma F. Central and peripheral effects of iminodipropionitrile on catecholamine metabolism in rats. Synapse. 2:1988;23-27.
11. Cadet J.L., Braun T., Freed W.J. Clonidine and prazosine block the iminodipropionitrile (IDPN)-induced spasmodic dyskinetic syndrome in mice. Pharmacol. Biochem. Behav. 26:1987;791-795.
12. 2 antagonist. Ro22-1319, inhibits the persistent behavioral syndrome induced by iminodipropionitrile in mice. Exp. Neurol. 96:1987;594-600.
13. 2 serotonin receptors in discrete regions of brain in the rat model of persistent dyskinesias induced by iminodipropionitrile (IDPN): evidence from autoradiographic studies. Brain Res. 437:1987;383-386.
14. Cadet J.L., Rothman R.B. Decreased striatal opiate receptors in the rat model of persistent dyskinesia induced by iminodipropionitrile. Neurosci. Lett. 72:1986;84-86.
15. 2) receptors in the iminodipropionitrile (IDPN) model of persistent dyskinesia in the rat. Neuropeptides. 10:1987;175-180.
16. Cambi F., Fung B., Chikaraishi D. 5′ Flanking DNA sequences direct cell-specific expression of rat tyrosine hydroxylase. J. Neurochem. 53:1989;1656-1659.
17. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
18. 1 dopamine receptor. Nature. 347:1990;72-76.
19. Diamond B.I., Sethi K., Borison R.L. Serotonin modulation of hyperkinesia and phasic neck dystonia induced by iminodipropionitrile (IDPN) in rats. Neurology. 36:1986;341.
20. Fazakerley J.K., Webb H.E. Cyclosporin, blood-brain barrier, and multiple sclerosis. Lancet. ii:1985;889-890.
21. Gianutsos G., Sudzak P.D. Neurochemical effects of IDPN on the mouse brain. Neurotoxicology. 6:1985;159-164.
22. Green A.R. 5-HT mediated behavior. Neuropharamacology. 23:1984;1521-1528.
23. Hagihara M., Fujimoto K., Takahashi A., Naoi M., Nagatsu T. Cyclosporin A, an immune suppressor, enhanced neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice. Neurochem. Int. 15:1989;249-254.
24. Handschumacher R.E., Harding M.W., Rice J., Drugge R.J., Speicher D.W. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science. 226:1984;544-547.
25. 2 receptors. Neuropharmacology. 24:1985;1201-1205.
26. Hirata H., Ogawa N., Asanuma M., Ota Z., Mori A. Effects of chronic ceruletide treatment on dopamine neurotransmitters, receptors and their mRNAs in the striatum of rats with dyskinesia induced by iminodipropionitrile. Brain Res. 604:1993;197-204.
27. Hopkins S.J., Rothwell N.J. Cytokines and the nervous system I: expression and recognition. Trends Neurosci. 18:1995;83-88.
28. Kondo Y., Ogawa N., Asanuma M., Nishibayashi S., Iwata E., Mori A. Cyclosporin A prevents ischemia-induced reduction of muscarinic acetylcholine receptors with suppression of microglial activation in gerbil hippocampus. Neurosci. Res. 22:1995;123-127.
29. Langlais P.J., Juang P.C., Gabay S. Regional neurochemical studies on the effects of β,β′-iminodipropionitrile (IDPN) in the rat. J. Neurosci. Res. 1:1975;419-425.
30. Matsuura K., Kabuto H., Makino H., Ogawa N. Cyclosporin A attenuates degeneration of dopaminergic neurons induced by 6-hydroxydopamine in the mouse brain. Brain Res. 733:1996;101-104.
31. Matsuura K., Makino H., Ogawa N. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine. Exp. Neurol. 146:1997;526-535.
32. McDonald M.L., Ardito T., Marks W.H., Kashgarian M., Lorber M.I. The effect of cyclosporine administration on the cellular distribution and content of cyclosporin. Transplantation. 53:1992;460-466.
33. 2-mediated head-twitch behavior and 5-HT receptor number in frontal cortex. Neuropharmacology. 24:1985;357-360.
34. 2 dopamine receptor gene. Biochemistry. 31:1992;8389-8396.
35. 2 dopaminergic receptor detected by in situ hybridization histochemistry in rata brain. FEBS Lett. 255:1989;335-339.
36. Ogawa N., Haba K., Asanuma M., Mori A. Long-lasting effect of ceruletide on dyskinesia and monoaminergic neuronal pathways in rats treated with iminodipropionitrile. Brain Res. 556:1991;271-279.
37. Ogawa N., Mizukawa K., Haba K., Sato H. Neurotransmitter and receptor alterations in the rat persistent dyskinesia model induced by iminodipropionitrile. Eur. Neurol. 30(Suppl. 1):1990;31-40.
38. Ogawa N., Tanaka K., Kondo Y., Asanuma M., Mizukawa K., Mori A. The preventive effect of cyclosporin A, an immunosuppressant, on the late onset reduction of muscarinic acetylcholine receptors in gerbil hippocampus after transient forebrain ischemia. Neurosci. Lett. 152:1993;173-176.
39. Palestine A.G., Nussenblatt R.B., Chan C. Cyclosporin penetration into anterior chamber of cerebrospinal fluid. Am. J. Ophthalmol. 99:1985;210-211.
40. Rothwell N.J., Hopkins S.J. Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci. 18:1995;130-136.
41. Schneider J.S. Role of basal ganglia in a chemically induced dyskinesia in rat. Exp. Neurol. 84:1984;524-532.
42. Schreiber E., Matthias P., Müller M.M., Schaffner W. Rapid detection of octamer binding protein with 'mini-extracts', prepared from a small number of cells. Nucleic Acid Res. 17:1989;6419.
43. Steiner J.P., Connolly M.A., Valentine H.L., Hamilton G.S., Dawson T.M., Hester L., Snyder S.H. Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A. Nat. Med. 3:1997;421-428.
44. Vivanco F., Ramos F., Jimenez-Diaz C. Determination of γ-aminobutyric acid and other free amino acids in whole brains of rats poisoned with β,β′-iminodipropionitrile and α,γ-diaminobutyric acid with or without administration of thyroxine. J. Neurochem. 13:1966;1461-1467.
45. Wilcek H., Ringden O., Tyden G. Cyclosporin-associated central nervous system toxicity after renal transplantation. Transplantation. 39:1985;110.
46. 1 receptor gene. J. Neurochem. 59:1992;1875-1883.
47. 1 dopamine receptors. Nature. 347:1990;76-80.